Mehdi Shishehbor, DO, PhD, discusses the 6-month results from his recent study, confirming the efficacy of the LimFlow System in patients with CLTI.
Mehdi H. Shishehbor, DO, PhD
Advertisement
Mehdi Shishehbor, DO, PhD, is the president of the Harrington Heart & Vascular Institute at University Hospitals.
Articles by Mehdi H. Shishehbor, DO, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Q&A: Intensive LDL Lowering and Cardiovascular Prevention Strategies, With Lawrence Leiter, MD
2
Synergy Between Metreleptin and GLP-1 Receptor Agonists in Lipodystrophy Real-World Data Suggest
3
Evaluating Clinical and Real-World Evidence in Hypercortisolism
4
Differential Diagnosis of Hypercortisolism
5